Search

Your search keyword '"E.-S. Kim"' showing total 237 results

Search Constraints

Start Over You searched for: Author "E.-S. Kim" Remove constraint Author: "E.-S. Kim"
237 results on '"E.-S. Kim"'

Search Results

1. Production of antihydrogen atoms by 6 keV antiprotons through a positronium cloud

2. Publisher Erratum: Production of antihydrogen atoms by 6 keV antiprotons through a positronium cloud

3. Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations

4. Present status and first results of the final focus beam line at the KEK Accelerator Test Facility

5. Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register 'Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)' (12-month follow-up)

6. Clinical features of post-COVID period. Results of an International Register 'Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)' (12-month follow-up)

7. Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry 'Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors'

8. Clinical features of post-COVID-19 period. Results of the international register 'Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)'. Data from 6-month follow-up

9. International register 'Dynamics analysis of comorbidities in SARS-CoV-2 survivors' (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19

10. International register 'Dynamics analysis of comorbidities in SARS-CoV-2 survivors' (AKTIV) and the register 'Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak' (AKTIV 2)

11. International register 'Dynamics analysis of comorbidities in SARS-CoV-2 survivors' (AKTIV SARS-CoV-2): analysis of 1,000 patients

14. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries

15. Parallelization of implementations of purely sequential algorithms

16. Malignant hyperthermia: current approaches to prevention and treatment

18. Real-world eligibility and cost-effectiveness analysis for empagliflozin in patients with heart failure

19. Characterization of myocardial proteomics in biopsy proven cardiomyopathies

21. P651 Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers

23. Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)

24. P086 Sirtuin 7 inhibitor attenuates colonic mucosal immune activation in mice–potential therapeutic target in Inflammatory Bowel Disease

25. P571 Frequency and risk factors of advanced neoplasia in Korean IBD patients with Low Grade Dysplasia in previous surveillance

26. P722 Compositional differences of gut microbiome using taxonomic profiling in patients with ulcerative colitis after treatment with vedolizumab

27. P560 Application of a clinical decision support tool for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicenter study

28. P233 Efficacy and safety of oral sulfate tablet for the bowel preparation in patients with inflammatory bowel disease: multicenter randomized controlled study

30. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)

31. [International register 'Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)']

32. P144 Changes of fecal metabolic and lipidomic features by anti-tumor necrosis factor treatment and prediction of clinical remission in patients with ulcerative colitis

33. MALIGNANT HYPERTHERMIA: CURRENT APPROACHES TO PREVENTION AND TREATMENT

34. DOP67 Comparison of the pharmacokinetics of CT-P13 between Crohn’s Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID

35. Detecting selection signatures between Duroc and Duroc synthetic pig populations using high-density SNP chip

36. P830 Genotype-based treatment with thiopurine reduces incidence of myelosuppression in patients with inflammatory bowel diseases

37. Global Performance Analysis of Deep Draft Semi-Submersible Designed for Standard GOM Application

38. Split Ring Resonator-based Bandpass Filter with Multi-Transmission Zeros and Flexibly Controllable Bandwidth Using Multipath Source-Load Couplings

39. P791 Difference between paediatric Crohn’s disease and ulcerative colitis at diagnosis in Korea: results from a multicentre, registry-based, retrospective cohort study

40. P809 Increase of tuberculosis due to combination therapy in inflammatory bowel disease: a nationwide population-based study in Korea

41. P494 The efficacy and safety of adalimumab for patients with moderately to severely active ulcerative colitis and predictors of response in Korea

42. Cavity beam position monitor system for the Accelerator Test Facility 2

43. Supplementary_material - Identification of aldo-keto reductase (AKR7A1) and glutathione S-transferase pi (GSTP1) as novel renal damage biomarkers following exposure to mercury

44. Effect of a Gene Polymorphism (g.3350G>C) on Meat Quality Traits in Berkshire

45. Development of a low Q cavity type beam position monitoring system

46. Design of the RAON accelerator systems

47. Identification of Lactic Acid Bacteria in Pork Meat and Pork Meat Products Using SDS-PAGE, 16S rRNA Gene Sequencing and MALDI-TOF Mass Spectrometry

49. P477 The efficacy of adalimumab for the treatment of Korean patients with ulcerative colitis and predictors of response: Preliminary results

50. Mortality and Risk Factors for Bacteremia in Patients with Cutaneous T-Cell Lymphoma (CTCL) at Emory University

Catalog

Books, media, physical & digital resources